Corticosteroids for ARDS

Minerva Anestesiologica

Volumn 76, Issue 6, 2010, Pages 441-447

  Thompson, B T ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adrenal cortex hormones; Glucocorticoids; Respiratory distress syndrome, adult

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; METHYLPREDNISOLONE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE DURATION; DRUG MECHANISM; DRUG MEGADOSE; FATALITY; HIGH RISK PATIENT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUNG FUNCTION; MORTALITY; PROTEIN FUNCTION; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREND STUDY; CLINICAL TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME, ADULT;

ADRENAL CORTEX HORMONES; CLINICAL TRIALS AS TOPIC; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 77955010911     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Lamberts SWJ, Bruining HA, De Jong F. Corticosteroid therapy in severe illness. N Engl J Med 1997;337:1285-92.
2. Chirousos GP. Seminars in medicine of the Beth Israel Hospital, Boston: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332:1351-62.
3. Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endo Metab 2006;91:3725-45.
4. Udelsman R, Ramp J, Gallucci WT, Gordon A, Lipford E, Norton JA et al. Adaptation during surgical stress: a reevaluation of the role of glucocorticoids. J Clin Invest 1986;77:1377-81.
5. MacLaren R, Jung R. Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill patients. Pharmacotherapy 2002;22:1140-56.
6. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 2000;55:603-13.
7. Meduri GU, Kantangat S. Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: Time for a critical reappraisal. Crit Care Med 1998;26:630-3.
8. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009;135:181-93.
9. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IRBBBin mediation of immunosuppression by glucocorticoids. Science 1995;270:283-6.
10. Weigers JG, Reul JHMH. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharm Sci 1998;19:317-21.
11. Meduri GU. Duration of glucocorticoid treatment and outcome in sepsis. Chest 1998;114:355-6.
12. Gaillard RC, Turnill D, Sappino P, Muller AF. Tumor necrosis factor ffinhibits the hormonal response to the pituitary gland to hypothalamic releasing factors. Endocrinology 1990;127:101-6.
13. Sandberg AA, Eik-Nes K, Migeon CJ, Samuels LT. et al. Metabolism of adrenal steroids in dying patients. J Clin Endocrinol Metab 1956;16:1001-16.
14. Jurney TH, Cockrell JL Jr, Lindberg JS, Lamiell JM, Wade CE. Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality. Chest 1987;92:292-5.
15. Reincke M, Allolio B, Wurth G, Winkelmann W. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 1993;77:151-6.
16. Barton RN, Stoner HB, Watson SM. Relationships among plasma cortisol, adrenocorticotrophin, and severity of injury in recently injured patients. J Trauma 1987;27:384-92.
17. Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995;23:78-83.
18. Jarek MJ, Legare EJ, McDermott MT, Merenich JA, Kollef MH. Endocrine profiles for outcome prediction from the intensive care unit. Crit Care Med 1993;21:543-50.
19. Shenker Y, Skatrub JB. Adrenal insufficiency in critically ill patients. Am J Respir Crit Care Med 2001;163:1520-3.
20. Moran JL, Chapman MJ, O'Fathartaigh MS, Peisach AR, Pannall PR, Leppard P. Hypocortisolaemia and adrenocortical responsiveness at the onset of septic shock. Intensive Care Med 1994;20:489-95.
21. Cunningham SK, Moore A, McKenna TJ. Normal cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med 1983;143:2276-9.
22. Sibbald WJ, Short A, Cohen MP, Wilson RF. Variations in adrenocortical responsiveness during severe bacterial infections: unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 1977;186:29-33.
23. Annane D, Sebille V, Troche G, Raphaël JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45.
24. Finlay WEI. Serum cortisol levels in severely stressed patients. Lancet 1982;1:1414-5.
25. Steinberg KP, Milberg JA, Martin TR, Maunder RJ, Cockrill BA, Hudson LD. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome: prognostic indicators. Am J Respir Crit Care Med 1998;150:113-22.
26. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:602-11.
27. Weigelt JA, Norcross JF, Borman KR, Snyder WH 3rd. Early steroid therapy for respiratory failure. Arch Surg 1985;120:536-40.
28. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138:62-8.
29. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987;92:1032-6.
30. Schein RM, Bergman R, Marcial EH, Schultz D, Duncan RC, Arnold PI, Sprung CL. Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome. Chest 1987;91:850-4.
31. Peter JV, John P, Graham PL, Moran JL, Abraham I, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008;336:1006-9.
32. Carlet J. From mega to more reasonable doses of corticosteroids: A decade to recreate hope. Crit Care Med 1999;27:672-4.
33. Bernard G, Luce J, Sprung C, Rinaldo JE, Tate RM, Sibbald WJ et al. High dose corticosteroids in patients with adult respiratory distress syndrome. N Engl J Med 1987;317:1565-70.
34. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial. JAMA 1998;280:159-65.
35. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-84.
36. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ et al. Methylprednisolone infusion in early severe ARDS. Chest 2007;131:954-63.
37. Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006;34:22-30.
38. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G et al. Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study. Am J Respir Crit Care Med 2005;171:242-8.
39. Agarwal R, Nath A, Aggarwal AN, Gupta D. Do corticosteroids decrease mortality in acute respiratory distress syndrome? Respirology 2007;12:585-90.
40. Tang BM, Craig J, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009;37:1594-603.
41. Meduri G, Marik P, Chrousos G, Pastores S, Arlt W, Beishuizen A et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008;34:61-9.
42. Bassler D, Ferreira-Gonzalez I, Briel M, Cook DJ, Devereaux PJ, Heels-Ansdell D et al. Systematic Reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol 2007;60:869-73.
43. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282:54-61.
44. Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005;33:1-6.
45. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007;176:886-91.
46. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B et al. for the National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network; Comparison of Two Fluid-Management Strategies in Acute Lung Injury. New Engl J Med 2006;354:2564-75.
47. Jabre P, Combes X, Lapostolle F, Dhaouadi M, Ricard-Hibon A, Vivien B et al.; KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009;374:293-300.
48. Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989;321:569-57.
49. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312:152-8.
50. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW, La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1440-50.
51. Annane D. Glucocorticoids for ARDS: just do it! Chest 2007;131:945-6.
52. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.
53. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K et al. for the CORTICUS Study Group. Hydrocortisone Therapy for Patients with Septic Shock. NEJM 2008;358:111-24.
54. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al.; International Surviving Sepsis Campaign Guidelines Committee; Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
55. The ARDS Network Authors. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome. JAMA 2000;283:1995-2002.
56. Haller M, Briegel J, Schelling G, Stoll C, Kapfhammer HP, Rothenhäusler HB et al. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. Critical Care Medicine 1999;27:2678-83.